Yasser Albogami

Yasser Albogami,

Department: Pharmaceutical Outcomes & Policy
Business Email: yalbogami@ufl.edu

Publications

2023
Concordance of neonatal critical condition data between secondary databases: Florida and Texas birth certificate Linkage with medicaid analytic extract.
BMC medical research methodology. 23(1) [DOI] 10.1186/s12874-023-01860-5. [PMID] 36803103.
2022
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data.
Pharmacoepidemiology and drug safety. 31(1):100-104 [DOI] 10.1002/pds.5371. [PMID] 34657354.
2022
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
American journal of obstetrics and gynecology. 227(2):263.e1-263.e38 [DOI] 10.1016/j.ajog.2022.01.004. [PMID] 35032444.
2021
Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort study.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 17(5):939-946 [DOI] 10.1016/j.soard.2021.01.025. [PMID] 33648887.
2021
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes.
Diabetes care. 44(6):1344-1352 [DOI] 10.2337/dc20-1794. [PMID] 33875487.
2021
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
Drug safety. 44(4):447-454 [DOI] 10.1007/s40264-021-01053-3. [PMID] 33683646.
2021
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.
Diabetes care. 44(8) [DOI] 10.2337/dci21-0024. [PMID] 34285101.
2020
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
BMJ quality & safety. 29(8):636-644 [DOI] 10.1136/bmjqs-2019-010098. [PMID] 31649165.
2020
Impact of the Transition from ICD-9-CM to ICD-10-CM on the Identification of Pregnancy Episodes in US Health Insurance Claims Data.
Clinical epidemiology. 12:1129-1138 [DOI] 10.2147/CLEP.S269400. [PMID] 33116906.
2020
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study.
Pharmacoepidemiology and drug safety. 29(6):716-724 [DOI] 10.1002/pds.5017. [PMID] 32347619.
2020
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy.
Pharmacoepidemiology and drug safety. 29(11):1414-1422 [DOI] 10.1002/pds.5126. [PMID] 32909348.
2017
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 25(6):868-872 [DOI] 10.1016/j.jsps.2017.01.004. [PMID] 28951672.
2016
Repeat Tdap Vaccination and Adverse Birth Outcomes.
JAMA. 315(12):1285-6 [DOI] 10.1001/jama.2015.19078. [PMID] 27002454.
2012
The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country.
Drug safety. 35(7):555-61 [DOI] 10.2165/11597450-000000000-00000. [PMID] 22671865.

Contact Details

Emails:
Business:
yalbogami@ufl.edu
Addresses: